ArborGen announced that it has entered into an agreement with Vallourec S.A. that gives ArborGen exclusive rights to develop and commercialise Vallourec's genetically improved eucalyptus clones in Brazil. The partnership will expand the products ArborGen can offer its customers, as well as allow it to expand into new markets in Brazil. The company will begin offering Vallourec seedlings in November 2020.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.164 NZD | +1.23% | +5.81% | -2.96% |
Apr. 09 | ArborGen Updates Net Debt, Earnings Guidance for Fiscal 2024 | MT |
2023 | ArborGen Posts 167% Jump in Fiscal H1 Gross Profit; Expects Record Full-Year Revenue | MT |
EPS Revisions
Annual profits - Rate of surprise
- Stock Market
- Equities
- ARB Stock
- News ArborGen Holdings Limited
- ArborGen Announces an Agreement with Vallourec S.A